INTEGRATED DIGITAL APPROACH FOR EARLY RISK PREDICTION OF ABDOMINAL ADHESIVE DISEASE BASED ON IMMUNO-MOLECULAR MARKERS

Abstract

Abdominal adhesive disease (AAD) remains a significant postoperative complication in abdominal surgery, contributing substantially to morbidity, recurrent intestinal obstruction, and healthcare burden worldwide. Despite advances in surgical techniques, current clinical strategies are largely empirical and do not adequately account for individual immunological variability.